Literature DB >> 4827366

Characterization of a phosphoglycerate kinase variant associated with hemolytic anemia.

A Yoshida, S Miwa.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4827366      PMCID: PMC1762628     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


× No keyword cloud information.
  11 in total

1.  Red cell phosphoglycerate kinase deficiency. A new cause of non-spherocytic hemolytic anemia.

Authors:  A P Kraus; M F Langston; B L Lynch
Journal:  Biochem Biophys Res Commun       Date:  1968-01-25       Impact factor: 3.575

2.  Glucose 6-phosphate dehydrogenase of human erythrocytes. I. Purification and characterization of normal (B+) enzyme.

Authors:  A Yoshida
Journal:  J Biol Chem       Date:  1966-11-10       Impact factor: 5.157

3.  [Congenital hemolytic anemia associated with phosphoglycerate kinase deficiency in erythrocytes, polynuclear cells and lymphocytes].

Authors:  P Cartier; B Habibi; J P Leroux; J C Marchand
Journal:  Nouv Rev Fr Hematol       Date:  1971 Jul-Aug

4.  Erythrocyte and leukocyte phosphoglycerate kinase deficiency with neurologic disease.

Authors:  P N Konrad; D J McCarthy; A M Mauer; W N Valentine; D E Paglia
Journal:  J Pediatr       Date:  1973-03       Impact factor: 4.406

5.  Phosphoglycerate kinase: additional variants and their geographic distribution.

Authors:  S H Chen; E R Giblett
Journal:  Am J Hum Genet       Date:  1972-03       Impact factor: 11.025

6.  Electrophoresis of phosphoglycerate kinase.

Authors:  E Beutler
Journal:  Biochem Genet       Date:  1969-04       Impact factor: 1.890

7.  Hereditary hemolytic anemia associated with phosphoglycerate kinase deficiency in erythrocytes and leukocytes. A probable X-chromosome-linked syndrome.

Authors:  W N Valentine; H S Hsieh; D E Paglia; H M Anderson; M A Baughan; E R Jaffé; O M Garson
Journal:  N Engl J Med       Date:  1969-03-06       Impact factor: 91.245

8.  Phosphoglycerate kinase: an X-linked polymorphism in man.

Authors:  S H Chen; L A Malcolm; A Yoshida; E R Giblett
Journal:  Am J Hum Genet       Date:  1971-01       Impact factor: 11.025

9.  Human phosphoglycerate kinase. I. Crystallization and characterization of normal enzyme.

Authors:  A Yoshida; S Watanabe
Journal:  J Biol Chem       Date:  1972-01-25       Impact factor: 5.157

10.  X-linkage of human phosphoglycerate kinase confirmed in man-mouse and man-Chinese hamster somatic cell hybrids.

Authors:  P Meera Khan; A Westerveld; K H Grzeschik; B F Deys; O M Garson; M Siniscalco
Journal:  Am J Hum Genet       Date:  1971-11       Impact factor: 11.025

View more
  5 in total

1.  The red cell 3 phosphoglycerate kinase polymorphism. Report of a new allele.

Authors:  J Y Le Gall; C Mubamba; Y Godin
Journal:  Hum Genet       Date:  1976-12-15       Impact factor: 4.132

2.  Phosphoglycerate kinase: studies on normal and a mutant human enzyme.

Authors:  L G Svirklys; C S Lee; W J O'Sullivan
Journal:  J Inherit Metab Dis       Date:  1986       Impact factor: 4.982

3.  Normal mRNA content in a phosphoglycerate kinase variant with severe enzyme deficiency.

Authors:  K Tani; T Takizawa; A Yoshida
Journal:  Am J Hum Genet       Date:  1985-09       Impact factor: 11.025

4.  Characterization of a phosphoglycerate kinase deficiency variants not associated with hemolytic anemia.

Authors:  W K Krietsch; S W Eber; B Haas; W Ruppelt; G W Kuntz
Journal:  Am J Hum Genet       Date:  1980-05       Impact factor: 11.025

5.  Manganese superoxide dismutase as a target of autoantibodies in acute Epstein-Barr virus infection.

Authors:  K Ritter; R J Kühl; F Semrau; H Eiffert; H D Kratzin; R Thomssen
Journal:  J Exp Med       Date:  1994-11-01       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.